All News

While a pediatric cancer diagnosis can obviously impact the child experiencing the disease, psychosocial effects can differentiate how each parent is affected, too.

With new therapies that can target specific genetic mutations in patients with lung cancer, testing the tumor’s makeup is becoming increasingly important, according to Joshua Bauml, M.D.

Travel can be helpful, even while coping with cancer, maybe especially while coping with cancer.

What comfort can you offer when somebody tells you she or he has cancer or, more challenging, that cancer has returned or spread?

After a cancer diagnosis, is there anyone to blame?

I blended my career as an educator with my passion for testicular cancer awareness.

September is Blood Cancer Awareness month and CURE’s latest issue is dedicated to these diseases. And we have a sneak peek at what’s inside:

A recent study showed that socioeconomic status may explain racial and ethnic disparities found among childhood cancer survivors of certain cancers.

Prostate cancer is one of the most common cancers in males, with about one man in nine to be diagnosed during his lifetime, according to the American Cancer Society.

From an inaugural gathering in 2009 that attracted approximately 700 people, the Life and Liberty event has grown in size each year, with more than 4,000 patients in attendance at last September’s celebration. Organizers said about 6,000 were there this year.

Medical marijuana continues to receive mixed reviews in the world of health care, but for those affected by cancer, it offers a ray of hope. Celebrities like Olivia Newton-John confirm the benefits through their own personal use of the plant but many don't have access to it.

As it turns out, a side effect of cancer treatment can be cataracts. Over the last two years, I have battled cancer treatment-induced cataracts. The good news is they can be fixed and I can see again!

Researchers disagree on whether or not to monitor ovarian cancer survivors with frequent CA-125 tests. But this patient would rather have more information than less.

The mouth is also part of the body, and yet, it is only in the past few years that oncologists have begun recommending patients see a dentist before they begin treatment to be sure the teeth and gums are in good shape.

A new blood test may offer a less invasive alternative to tissue testing when identifying patients with non-small cell lung cancer (NSCLC) who could benefit from certain immunotherapies.

An expert discusses tips on how patients with cancer can manage their "scanxiety."

A 16-member team, including five patients with multiple myeloma, hiked through Iceland to raise money for disease research in hopes of finding a cure.

Living a post-cancer lifestyle means including your medical history on a health declaration form and learning to deal with the consequences.

Substitute thinking "life management" instead of "time management."

Dating after cancer can be scary, but dating with cancer can be down right daunting.

Nicholas J. Vogelzang, M.D., FASCO, FACP, has seen cancer through a variety of lenses – from oncologist to patient as well as caregiver – giving him a different perspective than most.

The value of rest for a cancer survivor is paramount.

The Food and Drug Administration (FDA) approved the use of Lumoxiti (moxetumomab pasudotox-tdfk) for patients with relapsed or refractory hairy cell leukemia (HCL) who previously had at least two prior systemic therapies, including treatment with a purine nucleoside analog.

As a testicular cancer survivor, self-care through exercise is very important to me.

A study published in Blood demonstrated the significant disparities found between insurance status and survival outcomes in patients of all ages with follicular lymphoma.

The words celebrities use carry an enormous amount of weight.

The Food and Drug Administration (FDA) granted priority review to Keytruda (pembrolizumab) monotherapy for the first-line treatment of patients with locally advanced or metastatic nonsquamous or squamous non-small cell lung cancer (NSCLC) whose tumors express PD-L1 without EGFR or ALK genomic tumor aberrations.

One oncology nurse developed the BARF scale so her young patients could better communicate how they were feeling.

I poignantly remember an eloquent wife of a patient who died of acute leukemia shared her analogy with me. She stated, “You know when my dog died, I got a card from my vet. When my husband died, I got nothing.”